Advanced Strategies for Sublingual and Buccal Drug Delivery

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: 20 December 2024 | Viewed by 3918

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, USA
Interests: design and evaluate pediatric dosage forms; enhance solubility and dissolution rate of poorly soluble drugs; enhance stability of nanosuspensions; design microemulsions and nanoemulsions for the transdermal delivery of ions and small molecules
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Tissue Biology and Therapeutic Engineering Laboratory, Institute of Biology and Chemistry of Proteins, UMR 5305, CNRS/University Claude Bernard Lyon 1, 7 Passage du Vercors, CEDEX 07, 69367 Lyon, France
Interests: seaweed; sulfated polysaccharide; respiratory virus; approved antivirals; antiviral activity; vaccine; vaccine adjuvant; sublingual
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In the past several years, we have witnessed a remarkable interest in sublingual and buccal drug delivery systems. The sublingual route is very attractive for low-dose therapeutic agents and drugs for emergency use such as pain reduction, acute angina pectoris, opioid addiction, and anaphylactic shock. The route has also been favorable for pediatric formulations since young children are unable to swallow tablets or capsules. The physiology of sublingual absorption provides an alternative to oral absorption for low-dose small molecules, peptides, or even proteins that are prone to degradation in the gastric intestinal tract. Potentially, this route can also be feasible for vaccines and other peptides and proteins delivered at very low doses with the help of solid lipid nano particles or other penetration enhancers. 

The purpose of this Special Issue of Pharmaceutics is to draw attention to the importance of sublingual and buccal delivery systems and to provide scientists with a platform to publish their novel research work in this area. 

This Special Issue seeks novel topics pertaining to “Advanced Strategies for Sublingual and Buccal Drug Delivery”. Original research as well as reviews will be considered for publication.

We look forward to receiving your contributions.

Dr. Hassan Almoazen
Dr. Claire Monge
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • permeability enhancement
  • sublingual absorption
  • buccal absorption
  • fast-dissolving film
  • fast-dissolving tablet
  • under the tongue solution spray
  • prodrugs design
  • pediatric formulations
  • drug stability
  • drug solubility
  • microneedle sublingual patch
  • microneedle buccal patch
  • solid lipid nanoparticles
  • nanoemulsion
  • nanosuspension
  • colloidal dispersion

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 2701 KiB  
Article
Metronidazole Modified-Release Therapy Using Two Different Polymeric Systems Gels or Films: Clinical Study for the Treatment of Periodontitis
by Mônica Danielle Ribeiro Bastos, Tatiane Cristina Dotta, Beatriz Roque Kubata, Cássio do Nascimento, Ana Paula Macedo, Fellipe Augusto Tocchini de Figueiredo, Millena Mangueira Rocha, Maria Paula Garofo Peixoto, Maíra Peres Ferreira, Osvaldo de Freitas and Vinicius Pedrazzi
Pharmaceutics 2024, 16(9), 1108; https://doi.org/10.3390/pharmaceutics16091108 - 23 Aug 2024
Viewed by 372
Abstract
This study evaluated the efficacy of semisolid systems (gels) and films containing a combination of metronidazole (MTZ) and metronidazole benzoate after scaling and root-planing (SRP) for periodontitis. In total, 45 patients with stage I or II periodontitis were enrolled and divided into 3 [...] Read more.
This study evaluated the efficacy of semisolid systems (gels) and films containing a combination of metronidazole (MTZ) and metronidazole benzoate after scaling and root-planing (SRP) for periodontitis. In total, 45 patients with stage I or II periodontitis were enrolled and divided into 3 groups: 1—SRP—control; 2—SRP + Film with MTZ; 3—SRP + Gel with MTZ. The pH of gingival crevicular fluid (GCF) before/after treatments, MTZ concentrations, and drug release using high-performance liquid chromatography were investigated. The effects were evaluated by longitudinal monitoring of clinical parameters (probing depth—PD, clinical attachment level—CAL, and bleeding on probing—BP). MTZ and MTZ-benzoate concentrations in the periodontal pocket and pH showed no statistical difference after application. SRP + Gel presented the lowest CAL values. For SRP + Film and SRP + Gel, higher PD values were observed at T0 compared to all groups. A relevant reduction in BP was observed in SRP + Film and SRP + Gel groups at all times compared to T0. Both therapies improved periodontal health compared to SRP alone, reducing PD and BP, and increasing CAL for the gel group, suggesting they are promising for periodontal disease treatment. Full article
(This article belongs to the Special Issue Advanced Strategies for Sublingual and Buccal Drug Delivery)
Show Figures

Figure 1

38 pages, 8570 KiB  
Article
Development and Characterization of New Miconazole-Based Microemulsions for Buccal Delivery by Implementing a Full Factorial Design Modeling
by Marina-Theodora Talianu, Cristina-Elena Dinu-Pîrvu, Mihaela Violeta Ghica, Valentina Anuţa, Răzvan Mihai Prisada and Lăcrămioara Popa
Pharmaceutics 2024, 16(2), 271; https://doi.org/10.3390/pharmaceutics16020271 - 14 Feb 2024
Cited by 3 | Viewed by 1658
Abstract
This research aimed to develop miconazole-based microemulsions using oleic acid as a natural lipophilic phase and a stabilizer mixture comprising Tween 20 and PEG 400 to solubilize miconazole as an antifungal agent known for its activity in oral candidiasis and to improve its [...] Read more.
This research aimed to develop miconazole-based microemulsions using oleic acid as a natural lipophilic phase and a stabilizer mixture comprising Tween 20 and PEG 400 to solubilize miconazole as an antifungal agent known for its activity in oral candidiasis and to improve its bioavailability. The formulation and preparation process was combined with a mathematical approach using a 23-full factorial plan. Fluid and gel-like microemulsions were obtained and analyzed considering pH, conductivity, and refractive index, followed by extensive analyses focused on droplet size, zeta potential, rheological behavior, and goniometry. In vitro release tests were performed to assess their biopharmaceutical characteristics. Independent variables coded X1-Oleic acid (%, w/w), X2-Tween 20 (%, w/w), and X3-PEG 400 (%, w/w) were analyzed in relationship with three main outputs like mean droplet size, work of adhesion, and diffusion coefficient by combining statistical tools with response surface methodology. The microemulsion containing miconazole base–2%, oleic acid–5%, Tween 20–40%, PEG 400–20%, and water–33% exhibited a mean droplet size of 119.6 nm, a work of adhesion of 71.98 mN/m, a diffusion coefficient of 2.11·10−5 cm2/s, and together with remarked attributes of two gel-like systems formulated with higher oil concentrations, modeled the final optimization step of microemulsions as potential systems for buccal delivery. Full article
(This article belongs to the Special Issue Advanced Strategies for Sublingual and Buccal Drug Delivery)
Show Figures

Graphical abstract

14 pages, 2775 KiB  
Article
Permeation Protection by Waterproofing Mucosal Membranes
by Luisa Coderch, Cristina Alonso, Ana Cristina Calpena, Maria Luisa Pérez-García, Beatriz Clares-Naveros, Anderson Ramos and Meritxell Martí
Pharmaceutics 2023, 15(12), 2698; https://doi.org/10.3390/pharmaceutics15122698 - 29 Nov 2023
Cited by 1 | Viewed by 1095
Abstract
The permeability of the oral or nasal mucosa is higher than that of the skin. Mucosa permeability depends mainly on the thickness and keratinization degree of the tissues. Their permeability barrier is conditioned by the presence of certain lipids. This work has the [...] Read more.
The permeability of the oral or nasal mucosa is higher than that of the skin. Mucosa permeability depends mainly on the thickness and keratinization degree of the tissues. Their permeability barrier is conditioned by the presence of certain lipids. This work has the main aim of reinforcing the barrier effect of oral mucosa with a series of formulations to reduce permeation. Transmembrane water loss of different formulations was evaluated, and three of them were selected to be tested on the sublingual mucosa permeation of drugs. Caffeine, ibuprofen, dexamethasone, and ivermectin were applied on porcine skin, mucosa, and modified mucosa in order to compare the effectiveness of the formulations. A similar permeation profile was obtained in the different membranes: caffeine > ibuprofen~dexamethasone > ivermectin. The most efficient formulation was a liposomal formulation composed of lipids that are present in the skin stratum corneum. Impermeability provided by this formulation was notable mainly for the low-molecular-weight compounds, decreasing their permeability coefficient by between 40 and 80%. The reinforcement of the barrier function of mucosa provides a reduction or prevention of the permeation of different actives, which could be extrapolated to toxic compounds such as viruses, contaminants, toxins, etc. Full article
(This article belongs to the Special Issue Advanced Strategies for Sublingual and Buccal Drug Delivery)
Show Figures

Graphical abstract

Back to TopTop